tiprankstipranks

Anand Mehra Insider Profile

11 Followers
Anand Mehra, Director at Aclaris Therapeutics, holds 726.40K shares in Aclaris Therapeutics (Ticker: ACRS), holds ― shares in Merus (Ticker: MRUS), holds 0.00 shares in Spark Therapeutics (Ticker: ONCE).
tipranks
Anand Mehra

Anand Mehra
Aclaris Therapeutics (ACRS)
Director

Ranked #78,428 out of 109,030 Corporate Insiders

Profitable Transactions

63%
10 out of 16 Profitable Transactions

Average Return

-7.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
100.00%
A breakdown of Anand Mehra's holdings

Insider Roles

Aclaris Therapeutics
(ACRS)
Director
Roles that Anand Mehra holds in companies

Most Profitable Insider Trade

Stock:
Marinus
(MRNS)
Rating:Informative Buy
Date:Aug 06, 2014 - Aug 06, 2015
Return:+128.90%
The most profitable trade made by Anand Mehra

Anand Mehra's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Aclaris Therapeutics
Jun 08, 2026
Director
Uninformative Buy
50.49K
$3.86M
MRUS
Merus
ONCE
Spark Therapeutics
Dec 17, 2019
Uninformative Sell
59.71M
$0.00
AERI
Aerie Pharma
Apr 16, 2015
Informative Sell
14.29M
$7.16M
MRNS
Marinus
Oct 24, 2016
Informative Sell
1.04M
$15.40K
List of latest transactions for each holding click on a transaction to see Anand Mehra's performance on stock

Anand Mehra insider profile FAQ

What is the percentage of profitable transactions made by Anand Mehra?
The percentage of profitable transactions made by Anand Mehra is 63%.
    What is the average return per transaction made by Anand Mehra?
    The average return per transaction made by Anand Mehra is -7.40%.
      What stocks does Anand Mehra hold?
      Anand Mehra holds: ACRS, MRUS, ONCE, AERI, MRNS stocks.
        What was Anand Mehra’s latest transaction?
        Anand Mehra latest transaction was an Uninformative Buy of $50.49K.
          What was Anand Mehra's most profitable transaction?
          Anand Mehra’s most profitable transaction was an Informative Buy of MRNS stock on August 6, 2014. The return on the trade was 128.90%.
            What is Anand Mehra's role in Aclaris Therapeutics?
            Anand Mehra's role in Aclaris Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.